Multi-Morbidity in Hospitalised Older Patients: Who Are the Complex Elderly?

PLoS One. 2015 Dec 30;10(12):e0145372. doi: 10.1371/journal.pone.0145372. eCollection 2015.

Abstract

Background: No formal definition for the "complex elderly" exists; moreover, these older patients with high levels of multi-morbidity are not readily identified as such at point of hospitalisation, thus missing a valuable opportunity to manage the older patient appropriately within the hospital setting.

Objectives: To empirically identify the complex elderly patient based on degree of multi-morbidity.

Design: Retrospective observational study using administrative data.

Setting: English hospitals during the financial year 2012-13.

Subjects: All admitted patients aged 65 years and over.

Methods: By using exploratory analysis (correspondence analysis) we identify multi-morbidity groups based on 20 target conditions whose hospital prevalence was ≥ 1%.

Results: We examined a total of 2788900 hospital admissions. Multi-morbidity was highly prevalent, 62.8% had 2 or more of the targeted conditions while 4.7% had six or more. Multi-morbidity increased with age from 56% (65-69yr age-groups) up to 67% (80-84yr age-group). The average multi-morbidity was 3.2±1.2 (SD). Correspondence analysis revealed 3 distinct groups of older patients. Group 1 (multi-morbidity ≤2), associated with cancer and/or metastasis; Group 2 (multi-morbidity of 3, 4 or 5), associated with chronic pulmonary disease, lung disease, rheumatism and osteoporosis; finally Group 3 with the highest level of multi-morbidity (≥6) and associated with heart failure, cerebrovascular accident, diabetes, hypertension and myocardial infarction.

Conclusions: By using widely available hospital administrative data, we propose patients in Groups 2 and 3 to be identified as the complex elderly. Identification of multi-morbidity patterns can help to predict the needs of the older patient and improve resource provision.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Female
  • Heart Failure / mortality
  • Hospital Mortality*
  • Hospitalization
  • Humans
  • Hypertension / mortality
  • Length of Stay
  • Male
  • Morbidity
  • Myocardial Infarction / mortality
  • Prevalence
  • Retrospective Studies
  • Risk Factors
  • Stroke / mortality

Grants and funding

The Dr Foster Unit at Imperial is affiliated with the National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre. The NIHR Imperial Patient Safety Translational Research Centre is a partnership between the Imperial College Healthcare NHS Trust and Imperial College London. The Dr Foster Unit at Imperial is grateful for support from the NIHR Biomedical Research Centre funding scheme. The Unit is largely funded by a research grant from Dr Foster Intelligence (an independent health service research organisation).